Europe Cell Line Development Market Growth and Recent Trends by 2027
Europe Cell Line Development Market to 2027 - Regional Analysis and Forecasts by Type (Primary Cell Line, Hybridomas, Continuous Cell Lines, and Recombinant Cell Line); By Product (Equipment and Media & Reagent); Application (Drug Discovery, Bioproduction and Tissue Engineering); and Geography
- Report Date : Mar 2020
- Report Code : TIPRE00009032
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 114
The Europe cell line development market is expected to reach US$ 3,187.57 million in 2027 from US$ 1,214.01 million in 2019. The market is estimated to grow with a CAGR of 13.0% from 2020-2027.
The cell line is established cell culture, which gets increased numerous times when supplied with the growth medium and space for growth. Different cell lines can be made from different cells. The cell line plays a vital role in the study of cytology. The cell line enables stepwise alterations in the structure, physiology, and genetic makeup of cells under a customized environment.The scope of the cell line development market includes type, product, application, and region.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
EUROPE CELL LINE DEVELOPMENT MARKET SEGMENTATION
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
By Type
- Primary Cell Line
- Hybridomas
- Continuous Cell Lines
- Recombinant Cell Line
By Product
- Equipment
- Media & Reagent
By Application
- Drug Discovery
- Bioproduction
- Tissue Engineering
By Country
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Company Profiles
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- SELEXIS
- WuXiAppTec
- General Electric
- Lonza
- Corning Incorporated
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, By Product, Application, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
UK, Germany, France, Italy, Russia
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Cell line development Market – By Type
1.3.2 Cell line development Market – By Product
1.3.3 Cell line development Market – By Application
1.3.4 EuropeCell line development Market – By Country
2. Europe Cell Line Development Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. EuropeCell Line Development Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Cell Line Development Market- Europe PEST Analysis
4.3 Expert Opinion
5. Europe Cell Line Development Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Government Participation in the Cell Line Development Market
5.1.2 An Upsurge in the Development of the Biotechnology Industry
5.2 Market Restraints
5.2.1 Contamination of Cell Line by Microorganisms
5.3 Market Opportunity
5.3.1 Increasing Technological Advancements Regarding Cell Line Development
5.4 Future Trend
5.4.1 Growing Development of Innovative Products in the Cell Line Development Market
5.5 Impact Analysis
6. Cell Line Development Market – Europe Analysis
6.1 EuropeCell Line Development Market Revenue Forecasts and Analysis
7. EuropeCell Line Development Market Analysis and Forecasts To 2027 – ByType
7.1 Overview
7.2 Cell Line Development Market, by Type, 2019& 2027 (% Share)
7.3 Primary Cell Line
7.3.1 Overview
7.3.2 Primary Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Hybridomas
7.4.1 Overview
7.4.2 Hybridomas Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Continuous Cell Lines
7.5.1 Overview
7.5.2 Continuous Cell Lines Market Revenue and Forecast to 2027 (US$ Mn)
7.6 Recombinant Cell Line
7.6.1 Overview
7.6.2 Recombinant Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
8. Europe Cell Line Development Market Analysis and Forecasts To 2027 – ByProduct
8.1 Overview
8.2 Cell Line Development Market, by Product, 2019& 2027 (% Share)
8.3 Equipment
8.3.1 Overview
8.3.2 Equipment Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Media and Reagent
8.4.1 Overview
8.4.2 Media and Reagent Market Revenue and Forecast to 2027 (US$ Mn)
9. Europe Cell Line Development Market Analysis – ByApplication
9.1 Overview
9.2 Cell Line Development Market Share by Application 2019& 2027 (%)
9.3 Drug Discovery
9.3.1 Overview
9.3.2 Drug Discovery Market Revenue and Forecast to 2027 (US$ Mn)
9.4 Bioproduction
9.4.1 Overview
9.4.2 Bioproduction Market Revenue and Forecast to 2027 (US$ Mn)
9.5 Tissue Engineering
9.5.1 Overview
9.5.2 Tissue Engineering Market Revenue and Forecast to 2027 (US$ Mn)
10. Cell Line Development Market Revenue and Forecasts To 2027 – Geographical Analysis
10.1 Europe Cell Line Development Market Revenue and Forecast to 2027
10.1.1 Europe Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.2 Europe Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.1.3 Europe Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.1.4 Europe Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.1.5 Europe Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
10.1.6 Germany
10.1.6.1 Germany Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.6.2 Germany Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.1.6.3 Germany Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.1.6.4 Germany Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.1.7 UK
10.1.7.1 UK Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.7.2 UK Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.1.7.3 UK Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.1.7.4 UK Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.1.8 France
10.1.8.1 France Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.8.2 France Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.1.8.3 France Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.1.8.4 France Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.1.9 Spain
10.1.9.1 Spain Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.9.2 Spain Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.1.9.3 Spain Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.1.9.4 Spain Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.1.10 Italy
10.1.10.1 Italy Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.10.2 Italy Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.1.10.3 Italy Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.1.10.4 Italy Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
11. Impact of COVID-19 Pandemic on EuropeCell Line Development Market
11.1 Europe: Impact Assessment of COVID-19 Pandemic
12. Company Profiles
12.1 Merck KGaA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Financial Overview
12.1.4 Product Portfolio
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Thermo Fisher Scientific, Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Financial Information
12.2.4 Product /Services Portfolio
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 SELEXIS
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Financial Overview
12.3.4 Product/Service Portfolio
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 WuXi AppTec
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Financial Overview
12.4.4 Service Portfolio
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 General Electric
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Financial Overview
12.5.4 Product Portfolio
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Lonza
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Financial Information
12.6.4 Product Portfolio
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Corning Incorporated
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Financial Overview
12.7.4 Product Portfolio
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About the Insight Partners
13.2 Glossary of terms
LIST OF TABLES
Table 1. Europe Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 2. Europe Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 3. Europe Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 4. Germany Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 5. Germany Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 6. Germany Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 7. UK Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 8. UK Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 9. UK Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 10. France Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 11. France Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 12. France Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 13. Spain Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 14. Spain Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 15. Spain Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 16. Italy Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 17. Italy Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 18. Italy Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 19. Glossary of Terms, Cell Line Development Market
LIST OF FIGURES
Figure 1. Cell Line DevelopmentMarket Segmentation
Figure 2. EuropeCell Line Development Market Overview
Figure 3. Recombinant Cell Line Segment Held Largest Share of Typein Cell Line DevelopmentMarket
Figure 4. Germany is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Cell Line Development Market - Europe PEST Analysis
Figure 6. Cell Line Development Market Impact Analysis of Driver and Restraints
Figure 7. EuropeCell Line Development Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 8. Cell Line Development Market, Type, 2019& 2027 (% Share)
Figure 9. Primary Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
Figure 10. Hybridomas Market Revenue and Forecast to 2027 (US$ Mn)
Figure 11. Continuous Cell Lines Market Revenue and Forecast to 2027 (US$ Mn)
Figure 12. Recombinant Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
Figure 13. Cell Line Development Market, By Product, 2019& 2027 (% Share)
Figure 14. Equipment Market Revenue and Forecast to 2027 (US$ Mn)
Figure 15. Media and ReagentMarket Revenue and Forecast to 2027 (US$ Mn)
Figure 16. Cell Line Development Market Share by Application 2019& 2027 (%)
Figure 17. Drug Discovery Market Revenue and Forecast to 2027 (US$ Mn)
Figure 18. Bioproduction Market Revenue and Forecast to 2027 (US$ Mn)
Figure 19. Tissue Engineering Market Revenue and Forecast to 2027 (US$ Mn)
Figure 20. Europe Cell Line Development Market Revenue, By Country, 2019 (US$ Mn)
Figure 21. Europe Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 22. Europe Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
Figure 23. Germany Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 24. UK Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 25. France Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 26. Spain Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 27. Italy Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 28. Impact of COVID-19 Pandemic in Europe Country Markets
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- SELEXIS
- WuXiAppTec
- General Electric
- Lonza
- Corning Incorporated
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Mar 2020
Infectious Disease In vitro Diagnostics Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Application (HIV or AIDS, Tuberculosis, Hepatitis B and C, Malaria, and Others), End User (Hospitals and Clinics, Diagnostic Laboratories, Blood Bank, and Others), and Geography
Mar 2020
Donor Blood Components Market
Size and Forecast (2021–2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Blood Component (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Indication (Immunosuppression and Oncology), Application (Anemia Management, Thrombocytopenia Treatment, Coagulopathy Correction, Supportive Care During Chemotherapy, Surgery, and Others), Age Group (Adult and Child), End User (Hospitals, Oncology Centers, Transplant Centers, Ambulatory Surgical Centers, and Others), and Geography
Mar 2020
Aesthetic Injectable Devices Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Product (Dermal Filler, Botulinum Toxin and Others), Dermal Fillers (Calcium Hydroxylapatite, Hyaluronic Acid, Collagen, Poly-L-Lactic Acid, Polymethylmethacrylate, Fat Fillers, and Others), Device Type (Microcannulas, Pre-Filled Syringes, Mesotherapy Guns, and Others), Application (Facial Line Correction, Face Lift, Lip Treatment, Anti-Ageing and Wrinkle Treatment, Acne and Scar Treatment, Stretch Marks, and Others), Age Group (Up to 30, 31-40, 41-50, 51-60, and More Than 60), Gender (Female and Male), End User (Medical Spas, Dermatology Clinics, Hospitals, and Others), and Geography
Mar 2020
ECG Monitoring Equipment Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Resting ECG, Stress ECG, Holter Monitors, and Cardiopulmonary Stress Testing Monitors), Lead Type (12-Lead ECG, 3–6 Lead ECG, and Single Lead), Technology [Portable (Wired) ECG System and Wireless ECG System], End User (Hospital and Clinics, Ambulatory Surgical Centers, Cardiac Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2020
Prescription Drugs Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Product Type (Branded and Generics), Drug Type (Small Molecule and Biologics and Biosimilar), Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Diseases, Metabolic Diseases, Respiratory Diseases, Immunology, and Others), Route Of Administration (Oral, Injectable, Topical, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2020
Regenerative Dentistry Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Natural and Synthetic), Technology (Tissue Engineering, Stem Cell Therapy, and Others), Application (Periodontal Regeneration, Endodontic Regeneration, Tooth Reconstruction, Bone Regeneration, and Others), Age Group (Adult and Pediatric), End User (Dental Clinics, Hospital, and Others), and Geography
Mar 2020
Wound Closure Devices Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sutures, Adhesives, Staplers, Strips, and Others), Wound Type (Chronic Wound and Acute Wound), End User (Hospitals, Clinics, Ambulatory Surgery Centers, and Others), and Geography
Mar 2020
Cell and Gene Therapy Contract Development and Manufacturing Organization Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type (Drug Development and Manufacturing, Testing and Regulatory Services, and Others), Product Type (Gene Therapy and Cell Therapy), End User (Pharmaceutical Companies, Biopharmaceutical Companies, and Others), and Geography
Get Free Sample For